WuXi Biologics Recognized for Environmental Engagement in Sustainability for Consecutive Year

WuXi Biologics Achieves Recognition in Sustainability

WuXi Biologics, a top global Contract Research, Development, and Manufacturing Organization (CRDMO), has made significant strides in sustainability by being named to the esteemed CDP Supplier Engagement Assessment A List for the second consecutive year. This recognition is a testament to WuXi Biologics' leadership in engaging suppliers on pressing climate-related issues and reflects its exceptional performance in several areas, including governance, target-setting, and Scope 3 emissions disclosure.

The CDP SEA A List is a prestigious honor that symbolizes the highest level of commitment to environmental transparency and effective climate action across supply chains. Notably, in 2025, over 23,000 entities—from corporations to municipalities—submitted their environmental disclosures to CDP, further emphasizing the significance of this achievement. WuXi Biologics' proactive engagement with its suppliers to address Scope 3 emissions involves employing structured strategies, including thorough risk assessments, audits, training initiatives, incentive programs, and meticulous data tracking.

A Commitment to Environmental Strategies

At the core of WuXi Biologics’ approach to sustainability lies its alignment with the Science Based Targets initiative (SBTi). This includes setting ambitious short-term and net-zero greenhouse gas emissions reduction goals, with a pledge to attain net-zero emissions throughout its value chain by 2050. Dr. Chris Chen, the CEO of WuXi Biologics and Chairman of its ESG Committee, expressed pride in the company’s repeated recognition, highlighting it as a reflection of the ongoing efforts to enhance supplier collaboration and strengthen sustainability throughout the value chain.

WuXi Biologics’ commitment to promoting sustainability has not gone unnoticed, garnering accolades from several leading ESG rating agencies. These include MSCI AAA Ratings, EcoVadis Platinum Medals, and inclusion in prominent indices like the Dow Jones Best-in-Class World Index and Emerging Markets Index. The company has also received the highest negligible-risk ratings from Morningstar Sustainalytics, underscoring its status as an industry leader in ESG practices.

Driving Long-Term Sustainability

The ethos of WuXi Biologics revolves around the understanding that sustainability is pivotal for long-lasting business growth. Through continuous investments in technology innovations, the organization remains dedicated to providing advanced Green CRDMO solutions for its partners worldwide. This commitment aligns with their mission to collaborate with stakeholders in fostering a positive social impact and implementing responsible business practices that empower the entire value chain.

Currently, WuXi Biologics boasts a workforce of over 13,000 employees operating across several countries, including the United States, Ireland, Germany, and Singapore. With a focus on enabling partners to navigate the biologics development landscape, WuXi delivers tailored solutions that are efficient, scalable, and cost-effective. By integrating digital capabilities across the biopharmaceutical value chain, the organization transforms raw data into actionable insights that enhance client experiences and manufacturing efficiencies.

As of April 30, 2026, WuXi Biologics was supporting a staggering 982 integrated client projects, including 78 in Phase III and 25 in commercial manufacturing. Interestingly, complex modalities account for over half of the company's total project portfolio, highlighting its capability in handling sophisticated biopharmaceutical challenges.

In summary, WuXi Biologics has firmly established itself as a leader in sustainable practices in the biopharmaceutical industry, driving meaningful engagements with suppliers to enhance climate action within its value chain. Its recognition on the CDP Supplier Engagement A List not only acknowledges past efforts but also sets a forward-looking agenda in supporting environmentally responsible operations globally.